Optimized Allele-Specific Real-Time PCR Assays for the Detection of Common Mutations in KRAS and BRAF
- 31 January 2011
- journal article
- Published by Elsevier BV in The Journal of Molecular Diagnostics
- Vol. 13 (1), 23-28
- https://doi.org/10.1016/j.jmoldx.2010.11.007
Abstract
No abstract availableKeywords
Funding Information
- Land Vorarlberg
- Europäischer Fonds für regionale Entwicklung
This publication has 21 references indexed in Scilit:
- Analysis of PTEN, BRAF, and EGFR Status in Determining Benefit From Cetuximab Therapy in Wild-Type KRAS Metastatic Colon CancerJournal of Clinical Oncology, 2009
- Pyrosequencing method to detect KRAS mutation in formalin-fixed and paraffin-embedded tumor tissuesAnalytical Biochemistry, 2009
- KRAS codon 61, 146 and BRAF mutations predict resistance to cetuximab plus irinotecan in KRAS codon 12 and 13 wild-type metastatic colorectal cancerBritish Journal of Cancer, 2009
- Wild-Type BRAF Is Required for Response to Panitumumab or Cetuximab in Metastatic Colorectal CancerJournal of Clinical Oncology, 2008
- K-rasMutations and Benefit from Cetuximab in Advanced Colorectal CancerThe New England Journal of Medicine, 2008
- High resolution melting analysis for rapid and sensitive EGFR and KRAS mutation detection in formalin fixed paraffin embedded biopsiesBMC Cancer, 2008
- Wild-Type KRAS Is Required for Panitumumab Efficacy in Patients With Metastatic Colorectal CancerJournal of Clinical Oncology, 2008
- Application of a BRAF Pyrosequencing Assay for Mutation Detection and Copy Number Analysis in Malignant MelanomaThe Journal of Molecular Diagnostics, 2007
- Mutations of the BRAF gene in human cancerNature, 2002
- Kirsten ras mutations in patients with colorectal cancer: the ‘RASCAL II’ studyBritish Journal of Cancer, 2001